Search

Karen C. Carlson

Examiner (ID: 14133, Phone: (571)272-0946 , Office: P/1656 )

Most Active Art Unit
1656
Art Unit(s)
1652, 1635, 1812, 1651, 1814, 1642, 1653, 1656, 1611, 1801
Total Applications
2193
Issued Applications
1462
Pending Applications
175
Abandoned Applications
558

Applications

Application numberTitle of the applicationFiling DateStatus
Array ( [id] => 16541009 [patent_doc_number] => 20200407422 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2020-12-31 [patent_title] => A METHOD OF INTRACELLULAR DELIVERY [patent_app_type] => utility [patent_app_number] => 16/643964 [patent_app_country] => US [patent_app_date] => 2018-09-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 18791 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -19 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16643964 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/643964
A METHOD OF INTRACELLULAR DELIVERY Sep 4, 2018 Abandoned
Array ( [id] => 13774887 [patent_doc_number] => 20190000982 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2019-01-03 [patent_title] => METHODS, SYSTEMS AND COMPOSITIONS RELATING TO CELL CONVERSION VIA PROTEIN-INDUCED IN-VIVO CELL REPROGRAMMING [patent_app_type] => utility [patent_app_number] => 16/120829 [patent_app_country] => US [patent_app_date] => 2018-09-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 26654 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -14 [patent_words_short_claim] => 54 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16120829 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/120829
Methods, systems and compositions relating to cell conversion via protein-induced in-vivo cell reprogramming Sep 3, 2018 Issued
Array ( [id] => 14806303 [patent_doc_number] => 20190269761 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2019-09-05 [patent_title] => METHODS, COMPOSITIONS AND SCREENS FOR THERAPEUTICS FOR THE TREATMENT OF SYNOVIAL SARCOMA [patent_app_type] => utility [patent_app_number] => 16/115440 [patent_app_country] => US [patent_app_date] => 2018-08-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 21158 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -18 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16115440 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/115440
METHODS, COMPOSITIONS AND SCREENS FOR THERAPEUTICS FOR THE TREATMENT OF SYNOVIAL SARCOMA Aug 27, 2018 Abandoned
Array ( [id] => 14581879 [patent_doc_number] => 20190218548 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2019-07-18 [patent_title] => Method for Producing N-acetylglucosamine by Co-utilizing Glucose and Xylose Based on CRISPRi [patent_app_type] => utility [patent_app_number] => 16/112959 [patent_app_country] => US [patent_app_date] => 2018-08-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 3449 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -9 [patent_words_short_claim] => 44 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16112959 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/112959
Method for producing N-acetylglucosamine by co-utilizing glucose and xylose based on CRISPRi Aug 26, 2018 Issued
Array ( [id] => 14043921 [patent_doc_number] => 20190078067 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2019-03-14 [patent_title] => HALOACID DEHALOGENASE hdl4a PROTEIN VARIANT AND METHOD OF REDUCING CONCENTRATION OF FLUORINE-CONTAINING COMPOUND IN A SAMPLE USING THE SAME [patent_app_type] => utility [patent_app_number] => 16/107635 [patent_app_country] => US [patent_app_date] => 2018-08-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 4770 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -15 [patent_words_short_claim] => 26 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16107635 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/107635
HALOACID DEHALOGENASE hdl4a PROTEIN VARIANT AND METHOD OF REDUCING CONCENTRATION OF FLUORINE-CONTAINING COMPOUND IN A SAMPLE USING THE SAME Aug 20, 2018 Abandoned
Array ( [id] => 13870873 [patent_doc_number] => 20190031777 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2019-01-31 [patent_title] => Compositions and Methods for Detecting, Treating and Preventing Diseases and Disorders [patent_app_type] => utility [patent_app_number] => 16/106338 [patent_app_country] => US [patent_app_date] => 2018-08-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 27706 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -20 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16106338 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/106338
Compositions and methods for detecting, treating and preventing diseases and disorders Aug 20, 2018 Issued
Array ( [id] => 15963655 [patent_doc_number] => 20200165579 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2020-05-28 [patent_title] => A RECOMBINANT FLAVIN-ADENINE DINUCLEOTIDE GLUCOSE DEHYDROGENASE AND USES THEREOF [patent_app_type] => utility [patent_app_number] => 16/636013 [patent_app_country] => US [patent_app_date] => 2018-08-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 16012 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -18 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16636013 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/636013
Recombinant flavin-adenine dinucleotide glucose dehydrogenase and uses thereof Aug 1, 2018 Issued
Array ( [id] => 13774559 [patent_doc_number] => 20190000818 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2019-01-03 [patent_title] => Method To Predict Response To Pharmacological Chaperone Treatment Of Diseases [patent_app_type] => utility [patent_app_number] => 16/046247 [patent_app_country] => US [patent_app_date] => 2018-07-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 13187 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -19 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16046247 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/046247
Method to predict response to pharmacological chaperone treatment of diseases Jul 25, 2018 Issued
Array ( [id] => 13827179 [patent_doc_number] => 20190017074 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2019-01-17 [patent_title] => METHODS FOR GENOMIC INTEGRATION [patent_app_type] => utility [patent_app_number] => 16/044381 [patent_app_country] => US [patent_app_date] => 2018-07-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 39094 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -16 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16044381 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/044381
Methods for genomic integration Jul 23, 2018 Issued
Array ( [id] => 17200475 [patent_doc_number] => 20210340570 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2021-11-04 [patent_title] => COMPOSITIONS AND METHODS FOR INCREASING THE EFFICIENCY OF CELL CULTURES USED FOR FOOD PRODUCTION [patent_app_type] => utility [patent_app_number] => 16/630404 [patent_app_country] => US [patent_app_date] => 2018-07-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 22884 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -3 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16630404 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/630404
Compositions and methods for increasing the efficiency of cell cultures used for food production Jul 12, 2018 Issued
Array ( [id] => 15782511 [patent_doc_number] => 10624958 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2020-04-21 [patent_title] => Compositions and methods for treating pathological calcification and ossification [patent_app_type] => utility [patent_app_number] => 16/033948 [patent_app_country] => US [patent_app_date] => 2018-07-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 22 [patent_figures_cnt] => 28 [patent_no_of_words] => 25810 [patent_no_of_claims] => 25 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 59 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16033948 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/033948
Compositions and methods for treating pathological calcification and ossification Jul 11, 2018 Issued
Array ( [id] => 13778079 [patent_doc_number] => 20190002578 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2019-01-03 [patent_title] => Targeted Protein Degradation [patent_app_type] => utility [patent_app_number] => 16/024999 [patent_app_country] => US [patent_app_date] => 2018-07-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 16936 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -20 [patent_words_short_claim] => 32 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16024999 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/024999
Targeted protein degradation Jul 1, 2018 Issued
Array ( [id] => 13734081 [patent_doc_number] => 20180371508 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2018-12-27 [patent_title] => MICROBIAL PRODUCTION OF SUCCINATE DERIVED PRODUCTS [patent_app_type] => utility [patent_app_number] => 16/015101 [patent_app_country] => US [patent_app_date] => 2018-06-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 8361 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -12 [patent_words_short_claim] => 92 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16015101 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/015101
Microbial production of succinate derived products Jun 20, 2018 Issued
Array ( [id] => 18733553 [patent_doc_number] => 11802276 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2023-10-31 [patent_title] => Purification of polymerase complexes [patent_app_type] => utility [patent_app_number] => 15/989109 [patent_app_country] => US [patent_app_date] => 2018-05-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 16 [patent_figures_cnt] => 17 [patent_no_of_words] => 19805 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 192 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15989109 [rel_patent_id] =>[rel_patent_doc_number] =>)
15/989109
Purification of polymerase complexes May 23, 2018 Issued
Array ( [id] => 17858554 [patent_doc_number] => 11439692 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2022-09-13 [patent_title] => Method of treating diseases associated with MYD88 pathways using CRISPR-GNDM system [patent_app_type] => utility [patent_app_number] => 16/614145 [patent_app_country] => US [patent_app_date] => 2018-05-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 5 [patent_no_of_words] => 9646 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 34 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16614145 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/614145
Method of treating diseases associated with MYD88 pathways using CRISPR-GNDM system May 16, 2018 Issued
Array ( [id] => 16091127 [patent_doc_number] => 20200199550 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2020-06-25 [patent_title] => CELL COMPRISING A CHIMERIC ANTIGEN RECEPTOR (CAR) [patent_app_type] => utility [patent_app_number] => 16/613312 [patent_app_country] => US [patent_app_date] => 2018-05-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 8674 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -16 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16613312 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/613312
CELL COMPRISING A CHIMERIC ANTIGEN RECEPTOR (CAR) May 13, 2018 Abandoned
Array ( [id] => 14159197 [patent_doc_number] => 20190106701 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2019-04-11 [patent_title] => MICROORGANISMS AND METHODS FOR ENHANCING THE AVAILABILITY OF REDUCING EQUIVALENTS IN THE PRESENCE OF METHANOL, AND FOR PRODUCING 3-HYDROXYISOBUTYRATE OR METHACRYLIC ACID RELATED THERETO [patent_app_type] => utility [patent_app_number] => 15/979313 [patent_app_country] => US [patent_app_date] => 2018-05-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 52760 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -19 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15979313 [rel_patent_id] =>[rel_patent_doc_number] =>)
15/979313
MICROORGANISMS AND METHODS FOR ENHANCING THE AVAILABILITY OF REDUCING EQUIVALENTS IN THE PRESENCE OF METHANOL, AND FOR PRODUCING 3-HYDROXYISOBUTYRATE OR METHACRYLIC ACID RELATED THERETO May 13, 2018 Abandoned
Array ( [id] => 18301091 [patent_doc_number] => 11622977 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2023-04-11 [patent_title] => Materials and methods for engineering cells and uses thereof in immuno-oncology [patent_app_type] => utility [patent_app_number] => 16/613057 [patent_app_country] => US [patent_app_date] => 2018-05-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 103 [patent_figures_cnt] => 114 [patent_no_of_words] => 87417 [patent_no_of_claims] => 25 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 65 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16613057 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/613057
Materials and methods for engineering cells and uses thereof in immuno-oncology May 10, 2018 Issued
Array ( [id] => 13400057 [patent_doc_number] => 20180251571 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2018-09-06 [patent_title] => METHODS AND COMPOSITIONS FOR TREATMENT OF POMPE DISEASE [patent_app_type] => utility [patent_app_number] => 15/978075 [patent_app_country] => US [patent_app_date] => 2018-05-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 41003 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -19 [patent_words_short_claim] => 11 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15978075 [rel_patent_id] =>[rel_patent_doc_number] =>)
15/978075
METHODS AND COMPOSITIONS FOR TREATMENT OF POMPE DISEASE May 10, 2018 Abandoned
Array ( [id] => 14501275 [patent_doc_number] => 20190194292 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2019-06-27 [patent_title] => Enveloped Virus Resistant to Complement Inactivation for the Treatment of Cancer [patent_app_type] => utility [patent_app_number] => 16/303729 [patent_app_country] => US [patent_app_date] => 2018-05-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 3962 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -18 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16303729 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/303729
Enveloped virus resistant to complement inactivation for the treatment of cancer May 9, 2018 Issued
Menu